tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PRLD Stock Latest News

Prelude Therapeutics Announces CFO Transition and Interim Appointment
Company AnnouncementsPrelude Therapeutics Announces CFO Transition and Interim Appointment
15d ago
8K
PRLD
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
PremiumPress Releases
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
16d ago
PRLD
Prelude Therapeutics initiated with an Outperform at JMP Securities
PremiumThe Fly
Prelude Therapeutics initiated with an Outperform at JMP Securities
1M ago
PRLD
Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
PremiumPress Releases
Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
2M ago
PRLD
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference
PremiumPress Releases
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference
2M ago
PRLD
Prelude Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyPrelude Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
PRLD
New Accounting & Financial Operations Risk for Prelude Therapeutics, Inc. – What’s the Latest?
PremiumMarket News
New Accounting & Financial Operations Risk for Prelude Therapeutics, Inc. – What’s the Latest?
2M ago
PRLD
Prelude Therapeutics files to sell 7.94M shares of common stock for holders
PremiumThe Fly
Prelude Therapeutics files to sell 7.94M shares of common stock for holders
2M ago
PRLD
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
PremiumPress Releases
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
2M ago
PRLD
Prelude Therapeutics downgraded to Underweight at Morgan Stanley
PremiumThe Fly
Prelude Therapeutics downgraded to Underweight at Morgan Stanley
4M ago
PRLD
Prelude Therapeutics Announces $25 Million Private Placement
PremiumPress Releases
Prelude Therapeutics Announces $25 Million Private Placement
5M ago
PRLD
Prelude Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
PremiumThe Fly
Prelude Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
6M ago
PRLD
Prelude Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
PremiumThe FlyPrelude Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
6M ago
PRLD
Prelude Therapeutics price target lowered to $3 from $5 at Barclays
PremiumThe Fly
Prelude Therapeutics price target lowered to $3 from $5 at Barclays
6M ago
PRLD
Prelude Therapeutics updates pipeline ‘s clinical progress, prioritization
PremiumThe Fly
Prelude Therapeutics updates pipeline ‘s clinical progress, prioritization
6M ago
PRLD
Prelude, AbCellera team on precision antibody drug conjugates in oncology
PremiumThe Fly
Prelude, AbCellera team on precision antibody drug conjugates in oncology
6M ago
ABCL
PRLD
Prelude Therapeutics reports Q3 EPS (45c), consensus (58c)
PremiumThe Fly
Prelude Therapeutics reports Q3 EPS (45c), consensus (58c)
6M ago
PRLD
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
PremiumPress Releases
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
6M ago
PRLD
Prelude Therapeutics price target lowered to $6 from $17 at H.C. Wainwright
PremiumThe Fly
Prelude Therapeutics price target lowered to $6 from $17 at H.C. Wainwright
6M ago
PRLD
Prelude announces multiple clinical, preclinical presentations at AACR-NCI-EORTC
PremiumThe FlyPrelude announces multiple clinical, preclinical presentations at AACR-NCI-EORTC
6M ago
PRLD
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference 
PremiumPress Releases
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference 
6M ago
PRLD
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
PremiumPress Releases
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
8M ago
PRLD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >